Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1997Journal of Antimicrobial Chemotherapy

Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential

View Full Paper
Ask AI
Bookmark
Share

Authors

EREric RubinsteinCentre National de la Recherche ScientifiqueFBFrançois BompartDrugs for Neglected Diseases Initiative

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rubinstein et al. (1997) studied this question.

synapsesocial.com/papers/6a8bbfdddf3a83baf8caaa99https://doi.org/10.1093/jac/39.suppl_1.139
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococi with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics1992 · 74 citations
  2. 2Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features1993 · 113 citations
  3. 3The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination1992 · 69 citations
  4. 4Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk Factors1994 · 284 citations
  5. 5Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages1992 · 33 citations